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Abstract
Background Gating of single-photon emission computed
tomography (SPECT) has significantly improved the
reliability and diagnostic accuracy of myocardial perfusion
imaging. The functional parameters derived from this
technique, mainly left ventricular volumes and ejection
fraction, have been demonstrated to be accurate and
reproducible. They are able to increase the detection of
severe and extensive coronary artery disease and show a
significant incremental prognostic power over perfusion
abnormalities. Therefore, the importance given to gated
SPECT functional data has progressively grown.
Discussion This circumstance has further expanded the
indications for myocardial perfusion imaging and strength-
ened its position among the different imaging modalities.
Moreover, several studies show that the evaluation of
ventricular function may have a leading part in justifying
the execution of perfusion scintigraphy in various clinical
conditions.
Aim Aim of this review is to describe this evolution of
gated SPECT functional assessment from a supporting rank
with respect to perfusion, to a main actor position in the
field of cardiac imaging.
Keywords Gated single-photon emission computed
tomography . Left ventricular function .
Myocardial perfusion imaging
Introduction
The use of electrocardiographic gating has deeply modified
the scenario of myocardial perfusion single-photon emis-
sion computed tomography (SPECT). The simple visual-
isation of wall motion and thickening has greatly improved
the identification of attenuation artefacts, with a resultant
significant rise in specificity and diagnostic accuracy [1–3].
A number of studies have demonstrated that gated SPECT
evaluation of regional wall motion and wall thickening is
accurate both in baseline conditions and under stimulation,
and that it allows the recognition of stress-induced
abnormalities, as, for instance, in the case of post-ischaemic
stunning [4–7]. Furthermore, the available gated SPECT
processing software can measure the left ventricular
volumes and ejection fraction with good accuracy and high
reproducibility [8–36]. With time, the importance of the
functional data derived from gated images has steadily
increased. It has become clear that global and regional
functional parameters derived from gated SPECT can
improve the diagnostic capability of myocardial perfusion
imaging. Other studies have shown that assessment of the
left ventricular function by gated SPECT provides prog-
nostic information that is incremental to perfusion data. The
evaluation of regional wall motion has improved the
interpretation of segmental perfusion in various clinical
settings. The use of gated SPECT as a reliable modality for
examining the left ventricular contractile reserve on both a
regional and a global basis has become a reality, with
different possible applications. Finally, various recent
research papers have used gated SPECT to obtain func-
tional information, consigning the perfusion data to a
secondary rank or even neglecting them altogether. These
last reports suggest that, at least in the investigational
setting or for particular clinical indications, gated myocar-
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dial perfusion SPECT could be considered as an effective
substitute modality for the assessment of left ventricular
function. Thus, from an ancillary position with respect to
perfusion assessment, gated SPECT is progressively
achieving a major role in various clinical settings based
on its ability to evaluate left ventricular function. The
purpose of this review is to illustrate this expansion in gated
SPECT usage and to help to define its importance in the
present context of cardiac imaging.
Gated SPECT technique
A comprehensive exposition of the technical issues
concerning myocardial perfusion gated SPECT is be-
yond the scope of the present article. Various excellent
reviews have covered this topic [37–40]. The almost
universal use of gated SPECT for myocardial perfusion
imaging has been made possible by the availability of the
technetium-labelled perfusion agents, the propagation of
multihead gamma cameras, the increased power of
computer systems and the development of dedicated
software for processing of perfusion and functional data.
The presence of very important arrhythmic problems
remains the only reason for avoiding acquisition of a
perfusion study using electrocardiographic gating [37, 41,
42]. It must be considered that some major gating artefacts
may propagate even to the summed perfusion images and
thus affect their reliability [37]. The American Society of
Nuclear Cardiology proposed the limit of >20% of
premature beats to classify a patient as unsuitable for
gated SPECT [43]. However, the possibility of conveying
the counts of the heart cycles falling outside the selected
R-R acceptance window in an extra frame and the
capability offered by manufacturers of simultaneously
acquiring a gated and a non-gated study allow the use of
electrocardiographic gating in most patients with arrhyth-
mias. In these subjects, the summed frames will be usable
for perfusion assessment, whilst the gated data may remain
valuable for a visual estimate of ventricular function. In
the presence of heart rhythm disturbances, the assessment
of wall thickening is the most sensitive parameter, while
ejection fraction has been demonstrated to be a quite
robust measurement [41, 42].
The detection of ventricular boundaries is a crucial issue
for gated SPECT. Gamma camera resolution is still too low
in comparison to left ventricular wall thickness. Therefore,
because of the partial volume effect, myocardial wall
thickening is perceived as an apparent increase in count
density [44]. This brightening effect is used to estimate wall
thickening in gated SPECT studies [45]. On the other hand,
in patients with a relatively small left ventricular cavity, for
instance in women or children, or with left ventricular
hypertrophy, the endocardial border may be inaccurately
identified, leading to underestimation of the end-systolic
volume [46, 47]. This causes significant overestimation of
the left ventricular ejection fraction, although differences
exist in the degree of overestimation using the various
available processing algorithms [47, 48]. It has been
suggested that proper filtering and zooming may reduce
the inaccuracy of gated SPECT in these subjects [46, 47].
In spite of the finding of very small values in females, a
recent article has demonstrated that preserved left ventric-
ular ejection fraction and normal left ventricular volumes
have an incremental prognostic value over perfusion
abnormalities in women as well as in men [49]. This
suggests that the possible volume underestimation does not
impair the prognostic capability of gated SPECT [49].
The capability of the software program to correctly
identify the left ventricular border may be impaired in
regions with severely reduced tracer uptake. Many of the
patients with severe uptake defects, together with those
with left ventricular remodelling, have an altered left
ventricular shape. Although most software programs used
for gated SPECT functional measurements work on three-
dimensional data, the possibility of inaccurate results,
particularly underestimation of the ejection fraction, in left
ventricles with an irregular shape and wide uptake defects
must be considered [14, 16]. In general the published
reports indicate that the edge detection programs are able to
correctly define the ventricular borders even in patients
with severe hypoperfusion [5, 26, 50]. Most recent data
suggest that gated SPECT could be a valuable method to
assess abnormalities in left ventricular shape by means of a
ventricular shape index [51].
A debated point is whether gated SPECT should be
corrected for attenuation. There is no doubt that gating has
made a significant contribution to the identification of
attenuation artefacts in myocardial perfusion imaging [1–3].
However, Links et al. demonstrated that attenuation
correction of gated images improves both sensitivity (from
78% to 96%) and normalcy (from 62% to 85%) as
compared with non-corrected data sets [52]. The diagnostic
gain is particularly marked in patients with a high body
mass index; thus Thompson et al. observed that in patients
with a body mass index ≥30, attenuation correction
increased specificity from 41% to 76% and accuracy from
73% to 80%, with a limited loss in sensitivity (from 87% to
82%) [53]. The corresponding values obtained using
attenuation-corrected versus non-attenuation-corrected gat-
ed SPECT in patients with a body mass index <30 were:
specificity 82% versus 60%, accuracy 88% versus 85%,
and sensitivity 90% versus 90%, respectively [53]. It
appears reasonable to conclude that attenuation correction
and gated SPECT act synergistically in improving the
diagnostic reliability of myocardial perfusion imaging [54].
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Value of gated SPECT for estimating left ventricular
function
Several studies have convincingly demonstrated that there
is excellent agreement between gated SPECT and the other
established techniques in the measurement of left ventric-
ular function (volumes and ejection fraction), and a
complete description of the literature would go beyond
the aims of this review. Various algorithms have been
proposed for data processing and many of them are either
implemented on gamma camera systems or available as
commercial software. Quantitative Gated SPECT (QGS,
Cedars-Sinai Medical Center, Los Angeles, CA) is probably
the most widely used method [9]. It was initially compared
with first-pass radionuclide ventriculography, and the
correlation of the gated SPECT ejection fraction with the
reference standard was r=0.909 [9]. Subsequent studies
compared the QGS results with other reference techniques,
such as equilibrium radionuclide angiocardiography
(ERNA), echocardiography, contrast ventriculography and
magnetic resonance imaging [16, 19–21, 23, 26–36, 55].
The Emory Cardiac Toolbox (ECTb, Emory University,
Atlanta, GA) has also been extensively validated by compar-
ison with first-pass radionuclide ventriculography, ERNA,
echocardiography and magnetic resonance imaging [23, 25,
30, 34, 55]. Furthermore, comparative studies with ERNA
and magnetic resonance imaging have confirmed the
reliability of 4D-MSPECT (University of Michigan Medical
Center, Ann Arbor, MI) [32, 34, 55, 56]. Other quantitative
algorithms that have achieved commercial diffusion are the
MultiDim (Stanford University, Palo Alto, CA), the W-L CQ
(Yale University, New Haven, CT), the Left Ventricular
Global Thickening Fraction (LVGTF) and the Perfusion and
Functional Analysis for Gated SPECT (pFAST, Sapporo
Medical University, Sapporo, Japan) [57–60].
The relative accuracy and reliability of these methods
have been examined in various studies, comparing them
either with each other or with a reference standard. Everaert
et al. compared QGS and the Stanford University algorithm
with ERNA and observed high and very close correlations
(r=0.93 and r=0.94, respectively) of the two methods with
the reference standard [12]. In a similar study using 201Tl as
a perfusion agent, Vera et al. registered a slightly lower
degree of correlation between the above-mentioned two
methods and ERNA (r=0.80 for QGS and r=0.78 for the
Stanford University algorithm) and considerably lower
correlation values when gated SPECT was compared with
contrast left ventriculography (r=0.63 and r=0.61, respec-
tively, for the two algorithms) [24]. These data confirm
substantial agreement between the two examined quantita-
tive algorithms, but also emphasise the influence of the
reference standard on the achievable results. Using ERNA
as the reference, Nakajima et al. demonstrated good
correlation coefficients for the ejection fraction calculated
using the examined algorithms (QGS, ECTb, 4D-MSPECT
and pFAST) and even better correlation coefficients for the
end-diastolic volume: r=0.88 with QGS, r=0.89 with
ECTb, r=0.85 with 4D-MSPECT, r=0.90 with pFAST
[55]. Nichols et al. compared QGS and ECTb with regard
to ejection fraction and volumes, and demonstrated a very
close correlation between the two algorithms, but with a
systematic slight underestimation of end-diastolic volume
and ejection fraction using QGS [61]. Lum et al. compared
QGS, ECTb and 4D-MSPECT [62]. Although the correla-
tion coefficients between the algorithms were again
excellent, the Bland-Altman plot showed quite large
standard deviations. Moreover, these differences, in agree-
ment with the observations of Nakajima et al., were
influenced by the heart dimensions and by the presence of
perfusion defects [55, 61]. Therefore, although all methods
give reasonable results, it appears clear that the various
algorithms should not be used interchangeably.
To clarify the issue of the relative accuracy of various
algorithms, most recently Khalil et al. proposed the use of a
dedicated mathematical tool for the statistical analysis, the
regression without truth technique [63]. They compared
QGS, ECTb, LVGTF and the layer of maximum counts
(LMC), a relatively new, still commercially unavailable
method [64]. According to their analysis, QGS and ECTb
outperformed the other two methods, with the ECTb
showing a slight superiority over QGS, in part because
the latter was influenced by the severity of perfusion
defects [63]. Since magnetic resonance imaging is the true
gold standard for left ventricular volumetric and functional
assessment, in Table 1 we have summarised the studies
comparing gated SPECT with this reference technique. It
appears that the accuracy of gated SPECT quantitative
functional data is good and that no major differences exist
among the most widely available algorithms.
Independently of the accuracy of the measured data, a
major strength of gated SPECT is its high reproducibility.
Verberne et al. reported that in two repeated gated SPECT
acquisitions in 22 patients, the left ventricular ejection
fraction changed by just 0.9 units [65]. Comparable results
have been observed in patients with left ventricular
dysfunction due to ischaemic cardiomyopathy [66]. The
tracer dosage influences the degree of ejection fraction
reproducibility, which is greater in the case of high-dose
studies than in the low-dose studies of single-day protocols
[67]. Naturally, the above-mentioned differences among the
various quantitative algorithms preclude comparison of
values achieved using different procedures [34, 55]. On
the other hand, a recent inter-institutional study using the
same algorithm (QGS) showed a very good reproducibility
of the functional measurements performed by the different
centres and using different workstations [68].
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It has been shown that the lower limits of normalcy are
slightly different, especially in the case of the ejection
fraction, from those obtained using other imaging modal-
ities. Recent studies have tried to identify the normal values
in various groups of patients, demonstrating higher normal
left ventricular ejection fraction values in women than in
men. Particularly, the lower limit of normal ejection
fraction in men has been fixed at 41–43% and in women
at 49–51% [49, 69, 70]. Another important issue is the
gating interval chosen. In theory, 16 frames are more
accurate and reliable than the standard eight-interval gating,
as shown by the repeatedly demonstrated underestimation
of left ventricular ejection fraction using this latter
technique in comparison with standard modalities [14, 16,
17, 70]. However, relatively few data are available on direct
comparison between different framings in the same patients
[9, 71, 72]. The promising reports about the possibility of
analysing the diastolic function using gated SPECT would
justify the choice of a higher number of frames per cycle
[73]. Recent data suggest that improved reconstruction
techniques enhance the reliability of 16-interval gated
SPECT by reducing the image noise [35]. On the other
hand, the dependability and widespread experience with
eight-frame gating should be considered, and this approach
is still recommended for clinical routine [74].
With regard to the evaluation of regional function, gated
SPECT has been most extensively compared with echocar-
diography. The agreement in the classification of regional
wall motion abnormalities, taking into account wall
thickening data as well, is good to excellent, ranging form
56% to 91% [4, 5]. Interestingly, even in patients with wide
perfusion defects, such as those studied for the issue of
myocardial viability in the setting of ischaemic cardiomy-
opathy, the accordance between gated SPECT and echocar-
diography appears satisfactory, with 68% agreement and a
kappa statistics value of 0.54 [50]. Similar results have been
reported by other authors [75]. Most importantly, the
comparison with magnetic resonance imaging has con-
firmed the reliability of gated SPECT for regional dysfunc-
tion, with even higher exact agreement (83%) and a kappa
value of 0.77 [27].
Incremental diagnostic value of function over perfusion
Several reports have demonstrated that functional parame-
ters have an incremental value over perfusion alone for the
diagnosis of coronary artery disease and the evaluation of
its extent and severity [76–82]. It is well known that the
possibility of visualising the motion and thickening of
apparently hypoperfused segments significantly improves
the diagnostic accuracy of perfusion SPECT, particularly in
terms of increased specificity [2]. On the other hand, end-
diastolic perfusion images have been demonstrated to be
useful for improving the detection of mild perfusion
defects, especially in women and in patients with small
Table 1 Validation of gated SPECT left ventricular ejection fraction and volume measurements versus magnetic resonance imaging
Authors [ref. no.] No. of patients Method LVEF End-diastolic volume End-systolic volume
Mochizuki et al. [13] 18 Ref. no. [13] r=0.89 r=0.94 r=0.90
Stollfuss et al. [14] 26 Ref. no. [8] r=0.86
Vaduganathan et al. [17] 25 QGS r=0.93 r=0.81 r=0.92
Tadamura et al. [20] 20 QGS r=0.94 r=0.92 r=0.97
Tadamura et al. [21] 16 QGS r=0.89 r=0.89 r=0.93
Stollfuss et al. [22] 19 Ref. no. [8] r=0.71
Faber et al. [23] 10 QGS r=0.88 r=0.97 r=0.99
Bax et al. [27] 22 QGS r=0.90 r=0.84 r=0.87
Bavelaar-Croon et al. [28] 21 QGS r=0.85 r=0.94 r=0.95
Faber et al. [30] 35 QGS r=0.72 r=0.91 r=0.92
ECTb r=0.70 r=0.90 r=0.91
Thorley et al. [31] 50 QGS r=0.82 r=0.90
Lipke et al. [32] 54 QGS r=0.90 r=0.92 r=0.96
4D-MSPECT r=0.89 r=0.89 r=0.90
Persson et al. [33] 55 QGS r=0.83 r=0.96 r=0.95
Schaefer et al. [34] 70 QGS r=0.89 r=0.92 r=0.96
4D-MSPECT r=0.87 r=0.88 r=0.96
ECTb r=0.85 r=0.90 r=0.94
Marie et al. [35] 40 QGS r=0.93 r=0.93
Guterberlet et al. [36] 36 QGS r=0.79 r=0.91 r=0.94
ECTb r=0.72 r=0.91 r=0.93
LVEF left ventricular ejection fraction, ECTb Emory Cardiac Toolbox; QGS Quantitative Gated SPECT; Ref. no. reference number
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hearts, with a consequent increase in sensitivity [83]. In
some of these studies, however, the analysis of left
ventricular function is not just incremental over perfusion,
but also implies some specific piece of information which
does not appear achievable using perfusion data alone. For
the purpose of coronary artery disease detection and
evaluation, Sharir et al. examined the value of regional
wall motion abnormalities in the diagnosis of severe (≥90%
luminal diameter narrowing) and extensive (>1 vessel with
severe stenosis) coronary artery disease in patients with
normal resting perfusion and demonstrated that the assess-
ment of regional function had an incremental value over the
evaluation of perfusion defects [76]. For this particular
purpose the presence of regional wall motion abnormalities
showed a significantly higher sensitivity (88% vs 52%, p<
0.001, and 65% vs. 38%, p<0.03, respectively, in the left
anterior descending and the left circumflex territories) than
the finding of a severe perfusion defect, whereas the
specificity was just slightly and not significantly dimin-
ished. Emmett et al. observed that the analysis of regional
wall motion improved the specificity of myocardial
perfusion imaging in the diagnosis of coronary stenosis
>70% of the vessel lumen [77]. The exclusive contribution
of wall motion analysis was that the reversible wall motion
abnormalities were able to stratify the patients according to
the degree of angiographic coronary obstruction, with a
high positive predictive value for the presence of a stenosis
>80%. Of all gated SPECT variables, the stress wall motion
score and the difference wall motion score were the sole
scintigraphic predictors of the angiographic jeopardy score
in multivariate analysis [77]. Yamagishi et al. showed that
worsening by >5 ejection fraction units on post-exercise
gated SPECT increased the sensitivity of perfusion data for
the detection of multi-vessel coronary artery disease from
26.9% to 43.3%, with a decline in specificity from 100% to
90.4% [79]. Another paper by the same group demonstrated
that taking into account the presence of stress-induced
regional wall motion abnormalities significantly increased
the sensitivity of 201Tl gated SPECT for the detection of
right coronary artery lesions and for the recognition of
multi-vessel disease as compared to perfusion defects alone,
without affecting the specificity [80]. Similar results were
obtained by Lima et al., who demonstrated that adding the
functional abnormalities to clinical, stress and perfusion
data significantly increased the predictive power of gated
SPECT myocardial perfusion imaging for the identification
of three-vessel coronary artery disease [81].
These examples indicate that the functional parameters
derived from gated SPECT do not simply increase the
diagnostic accuracy of perfusion analysis, but are chiefly
valuable in characterising coronary artery disease in terms
of severity and extent. It is clear that this is of foremost
importance for orienting the patient management, allowing
not only better disease detection but also its timely
stratification.
Incremental prognostic value of function over perfusion
As just mentioned above, the current paradigm in coronary
artery disease management is that of a risk-based approach
[84]. Therefore, the main task of imaging procedures is to
help in defining patient prognosis, identifying those sub-
jects at risk for adverse events, mainly cardiac death or non-
fatal myocardial infarction. As regards prognostication,
several studies have examined the role of gated myocardial
perfusion SPECT [85–94]. In general, the functional
parameters improve the predictive models. Various reports,
however, have shown that functional evaluation using gated
SPECT is particularly important for the prediction of hard
events, above all cardiac death.
In a patient population of more than 1,600 patients,
Sharir et al. found that the ejection fraction and the end-
systolic volume were the sole significant multivariate
predictors of the two hard events (cardiac death or
myocardial infarction), and that the perfusion variables
became significant only if a soft event, such as late
revascularisation, was included in the analysis [85]. In
patients with any degree of significant perfusion abnormal-
ity, a post-stress ejection fraction <45% or end-systolic
volume >70 ml dramatically increased the rate of cardiac
death during follow-up. Interestingly, the end-systolic
volume was able to further stratify risk of cardiac death in
the patients with an abnormal ejection fraction. The same
authors, in a larger patient population of approximately
2,700 patients, examined separately the predictors of
cardiac death and non-fatal myocardial infarction [86].
They could demonstrate that the most powerful predictor of
cardiac death was the post-stress ejection fraction, whereas
the amount of ischaemia expressed as the summed
difference score was the best predictor of myocardial
infarction. Similarly, Kroll et al., studying patients with
recent myocardial infarction, identified the post-stress left
ventricular ejection fraction as the sole imaging predictor of
cardiac death or infarct recurrence; in their cohort, the
summed stress score was related to the occurrence of any
cardiac event (including soft events such as unstable
angina, congestive heart failure or late revascularisation),
but not of hard events alone [87]. In a patient population of
approximately 500 patients with a low ejection fraction
who were followed up for about 2 years, Bestetti et al.
demonstrated that the post-stress end-systolic volume was
the best predictor of cardiac events in univariate analysis,
followed by other functional parameters, such as resting
end-systolic and end-diastolic volumes, post-stress end-
diastolic volume and post-stress ejection fraction [88].
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Moreover, in multivariate analysis, the post-stress end-
systolic volume and ejection fraction were the two
significant predictors of hard events [88]. In the setting of
preoperative risk stratification, Hashimoto et al. observed
that gated SPECT functional data had a significant
predictive value in patients without perfusion abnormalities,
both for all cardiac events and for hard events only [89]. De
Winter et al. examined the role of gated SPECT in elderly
patients and confirmed the significant incremental value of
functional parameters over clinical and perfusion variables
[93]. They found that the resting and post-stress left
ventricular ejection fraction were the most significant
predictors of all-cause mortality and that the left ventricular
resting and post-stress end systolic volume were the best
predictors of cardiac death. Most recently, Bigi et al.
examined the prognostic power of gated SPECT in
hypertensive patients. In the presence of a normal perfusion
pattern, the event rate was low independently of the peak
stress end-systolic volume, but in the case of moderate-to-
severe perfusion defects, a peak end-systolic volume
>74 ml identified the patients with an adverse outcome
[94]. Furthermore, this parameter was significantly related
to the occurrence of cardiac death. Finally, a most recent
report by Sharir et al. has addressed the issue of the gender-
related differences in the prognostic value of left ventricular
volumes and ejection fraction [49]. According to these
authors, there is no influence of sex on the capability of
gated SPECT to effectively stratify the patient population.
In particular, after considering separate ranges of normal
ejection fraction, end-diastolic and end-systolic volume for
men and women, even in this last group there is a
significant incremental value of functional parameters for
prediction of hard events [49].
Therefore, functional data do not merely have an
additional prognostic value over the perfusion pattern;
rather, they appear specifically involved in the prediction
of cardiac death. In terms of risk-based patient manage-
ment, the extent of inducible ischaemia detected by gated
myocardial perfusion SPECT is the most effective predictor
of the potential benefit of early revascularisation compared
with medical therapy, but the left ventricular ejection
fraction stratifies the absolute life gain in the individual
patient [40].
Regional function and perfusion
The accuracy of gated SPECT for the assessment of wall
motion and thickening has been comprehensively demon-
strated [4–6, 20, 27, 50, 75, 95, 96]. Moreover, this
modality is perfectly suitable for exploring the relationship
between perfusion and function on a segmental basis,
because there are no realignment problems. A clinical
condition in which the interpretation of perfusion abnor-
malities without considering functional parameters can be
tricky is the left bundle branch block. Several years ago,
Sugihara et al. demonstrated that the decreased septal
thickening in these patients can mimic the presence of
hypoperfusion on non-gated images [97]. In a more recent
study, Kasai et al. demonstrated using gated SPECT that in
patients with left bundle branch block, septal wall thicken-
ing is reduced even in the presence of normal wall motion,
and that it is further decreased in the case of dyssynchro-
nous wall motion [98]. Therefore, gating appears mandato-
ry to interpret the meaning of defects in myocardial
perfusion imaging in patients with left bundle branch block.
Similarly, Giubbini et al. demonstrated that the combination
of functional (in particular wall thickening) and perfusion
data obtained from gated SPECT is very effective in order
to interpret the meaning of septal wall motion abnormalities
in patients submitted to coronary artery bypass grafting and
to differentiate between pseudo-paradoxical wall motion
caused by heart surgery and paradoxical wall motion in
patients with prior anterior myocardial infarction [99].
For the recognition of viable myocardium, gated SPECT
allows the classification of dysfunctional segments accord-
ing to their degree of baseline asynergy. It is therefore
possible to select different and more accurate activity
thresholds for each level of baseline dysfunction. Our
group demonstrated that two different activity cut-offs
(≥50% for the a/dyskinetic and >68% for the hypokinetic
segments, as classified by baseline gated SPECT) allowed
significantly more accurate (74% vs 64%, p<0.02) detec-
tion of segments with post-revascularisation recovery than
the use of the same threshold for all dysfunctional
segments [100]. The relation between segmental perfusion
and wall motion abnormalities has been used by Kurihara
et al. for the prediction of functional recovery after
primary angioplasty for acute myocardial infarction
[101]. The patients with a higher number of segments
with a perfusion/function mismatch pattern had a greater
increase in left ventricular ejection fraction 3 months after
primary angioplasty. Moreover, the number of matched
abnormal segments was related to the left ventricular
ejection fraction value at 3 months. In a more investiga-
tional setting, Marini et al. used the combination of
perfusion and functional data (segment wall motion and
thickening) to evaluate the regional washout of metaiodo-
benzylguanidine in patients with ischaemic and idiopathic
cardiomyopathy [102]. They could demonstrate that there
are significant differences in the metaiodobenzylguanidine
washout in normal versus hypoperfused dysfunctional
segments and that these differences are influenced by the
type of cardiomyopathy [102].
It is thus clear that the possibility of classifying segments
in terms of both perfusion and function is useful in order to
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accurately interpret the results of myocardial perfusion
imaging as well as those of other scintigraphic studies.
Gated SPECT for the assessment of contractile reserve
The reproducibility of gated SPECT regional wall motion
assessment made it a reliable tool for evaluating the
response to inotropic stimulation [6, 50, 103]. Low-dose
dobutamine gated SPECT has become a reality with
expanding fields of application. This approach has been
evaluated by various authors, who have demonstrated its
feasibility and appraised its merits. Yoshinaga et al.
compared it with fluorodeoxyglucose positron emission
tomography for the recognition of myocardial viability, and
reported a significant gain in specificity over perfusion data
(100% vs 52%, p<0.05) [104]. Considered alone, however,
the inotropic response is affected by a low sensitivity for
viable myocardium [105]. This was confirmed by our group
using the post-revascularisation functional recovery as a
reference criterion for myocardial viability: we registered
higher specificity (88% vs 55%) but lower sensitivity (64%
vs 85%) of inotropic response compared with perfusion
activity threshold criteria [106]. However, we could
demonstrate that a combined approach that defines viability
of hypokinetic segments according to their contractile
reserve (assessed using gated SPECT under dobutamine
infusion) and of a/dyskinetic segments according to their
tracer activity was significantly more specific (83%) and
accurate (81%) than perfusion imaging alone [106]. Other
groups have confirmed the value of combining perfusion
threshold and inotropic and/or ischaemic response with
low-dose dobutamine, even when using 201Tl as the
perfusion tracer or with a dual-isotope imaging protocol
[107–109]. Another most recent use of dobutamine gated
SPECT is that reported by Kumita et al. [110], who
demonstrated a relationship between the type of contractile
response, the stress-rest perfusion pattern and the fatty acid
metabolic status assessed by 123I-beta-methyl-iodophenyl-
pentadecanoic acid. Although still investigational, this
combined approach is certainly promising for the character-
isation of different diseases.
Taking advantage of the demonstrated reproducibility of
gated SPECT functional measurements, other authors have
examined the changes in global left ventricular functional
parameters under inotropic stimulation. The reaction to
low-dose dobutamine can be predictive of the left ventric-
ular functional response to revascularisation. Our group
observed that an ejection fraction increase by ≥5 units
during dobutamine predicted an increase of ≥5 units after
revascularisation with an accuracy of 77%, a positive
predictive value of 73% and a negative predictive value of
81% [111]. In patients with recent-onset idiopathic dilated
cardiomyopathy, Kasama et al. demonstrated that the
ejection fraction changes induced by low-dose dobutamine
and evaluated using gated SPECT were predictive of
spontaneous improvement at 1-year follow-up [112]. The
same authors demonstrated that dobutamine gated SPECT
could be used to predict the response to beta-blocker
therapy in these patients, whilst the perfusion pattern was
useless for this purpose [113]. According to their data, the
delta left ventricular ejection fraction under dobutamine
stimulation was significantly larger in responders to
carvedilol therapy than in non-responders [113]. Similarly,
Weytjens et al. studied with dobutamine gated SPECT the
contractile reserve of asymptomatic type 1 diabetics,
showing that they responded with an increase in ejection
fraction higher than that observed in the control subjects,
but produced by a decrease in end-systolic volume rather
than by an increase in end-diastolic volume [114]. The
authors concluded that this behaviour could be related to
subclinical abnormalities in diastolic function in diabetic
patients [114].
On the basis of these reports, it is reasonable to include
baseline low-dose dobutamine gated SPECT among the
stress tests that a nuclear cardiology laboratory must be able
to perform when appropriately indicated.
Gated SPECT for the evaluation of left ventricular
volumes and ejection fraction
Because of the reliability of gated SPECT measurements of
global left ventricular functional parameters, several studies
have employed gated SPECT to follow up the evolution of
left ventricular function or its response to therapeutic
interventions. In some of these studies, functional analysis
has been used together with the assessment of myocardial
perfusion, which remained the main indication for the
radionuclide scan, in order to investigate the relationship
between these parameters under different conditions.
Zellweger et al. studied patients after percutaneous coro-
nary interventions: they were able to document that the
improvement in extent of ischaemia was accompanied by a
beneficial effect on left ventricular volumes and function. In
patients without prior infarction they observed the presence
of reverse remodelling with a significant decrease in both
the end-diastolic and the end-systolic volume and a
significant increase in ejection fraction; conversely, patients
with previous infarction showed only a significant decrease
in end-systolic volume [115]. Ogard et al. used gated
SPECT to explore perfusion abnormalities and their
possible functional consequences in patients with primary
hyperparathyroidism without a history of previous myocar-
dial infarction, taking advantage of the use of 99mTc-
sestamibi for parathyroid imaging [116]. They identified
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unexpected significant (>15% of the left ventricular wall)
perfusion defects at rest in 5 out of 22 patients; the clinical
importance of these defects was confirmed by the detection
of lower ejection fraction values than in patients with
normal perfusion [116]. The authors concluded that the
acquisition of a gated SPECT study should be contemplated
in patients submitted to 99mTc-sestamibi parathyroid scin-
tigraphy, because it could be helpful to recognise patients
with unsuspected cardiac disease, in whom proper treat-
ment and peri-operative precautions should be considered
[116]. Most recently, Lima et al. employed gated SPECT to
examine the factors that are related to an abnormal heart
rate recovery after dynamic exercise, a well-known adverse
prognostic marker in coronary artery disease [117]. In
multivariate analysis, the extent and severity of the
perfusion defect at rest were just borderline significant
predictors of an abnormal heart rate recovery, whereas age,
resting heart rate and left ventricular ejection fraction
derived from gated SPECT were all highly significant
predictors; interestingly, exercise-induced ischaemia was
not a significant predictor [117]. This study emphasises the
importance of combining perfusion and functional data to
fully understand the physiopathology of dynamic exercise.
Other studies have used gated SPECT to assess the
response to drug therapy and for this purpose, perfusion
and functional data were equally important. Feola et al.
studied the changes in myocardial perfusion and global left
ventricular function induced by short-term treatment with
trimetazidine in patients with ischaemic ventricular dys-
function [118]. They demonstrated a significant improve-
ment in myocardial perfusion during treatment as compared
with the images obtained under placebo, and this improve-
ment was accompanied by a significant reduction in left
ventricular end-systolic volume and a significant increase in
the ejection fraction; however, in the subgroup of patients
with the most severe left ventricular dysfunction, the
perfusion recovery was not associated with a significant
functional improvement [118]. Thus, the functional effect
of treatment could be analysed taking into account also the
interaction between drug action and perfusion pattern.
Valgimigli et al. used gated SPECT to evaluate the response
to granulocyte-colony stimulating factor in patients with
acute myocardial infarction [119]. They compared the
changes in perfusion, end-diastolic volume and ejection
fraction in placebo versus treatment groups and demon-
strated that in the presence of a similar reduction in the
defect score, the treated group showed a trend towards an
improvement in ejection fraction and a lower increase in
end-diastolic volume [119]. This result implies that perfu-
sion changes alone could be misleading as the sole basis for
accurate evaluation of treatment outcome. This conclusion
is partly contradicted by the study by Kuethe et al., who
used gated SPECT to assess the changes in wall perfusion
and wall motion score and radionuclide ventriculography to
evaluate the evolution of ejection fraction in patients treated
by granulocyte-colony stimulating factor compared with a
placebo group. They registered a significant improvement
in both wall motion and perfusion scores in the treated
patients, together with a significant increase in ejection
fraction, whilst the patients under placebo therapy showed
neither perfusion nor functional improvements [120]. Most
recently, Beeres et al. used gated SPECT to examine the
effect of intramyocardial injection of autologous bone
marrow-derived cells on perfusion and function in patients
with severe, drug-refractory chronic ischaemia [121]. They
demonstrated with a single imaging modality improvement
in both stress-induced perfusion defects and left ventricular
function [121]. Interestingly, the same group was able to
verify that the improvement is not short-lived by identify-
ing the persistence of the ejection fraction increase at a later
12-month control, which was again performed using
perfusion gated SPECT [122]. The effectiveness of this
modality for follow-up studies is therefore confirmed.
Another interesting field of application for gated SPECT
is the treatment of severe heart failure. Fukuchi et al. used
gated SPECT to examine patients with established idio-
pathic dilated cardiomyopathy and demonstrated that the
perfusion defect extent and a sphericity index that they
obtained from gated SPECT volumes were both significant
predictors of the subsequent response to beta-blocker
therapy [123]. In these patients, the possibility of improving
both the clinical condition and the left ventricular function
using cardiac resynchronisation therapy with biventricular
pacing has recently opened up new therapeutic perspec-
tives. However, because of its costs and its potential
morbidity, this treatment should be reserved for those
patients who may benefit from it. The aetiology of left
ventricular dysfunction is one of the parameters that could
influence the response to resynchronisation therapy. We
used gated SPECT to evaluate the changes in left
ventricular volumes and ejection fraction in a small group
of patients submitted to cardiac resynchronisation therapy
and were able to demonstrate that improvement in
functional parameters was limited to patients with normal
myocardial perfusion, and was negligible or absent in those
with significant resting perfusion defects, independently of
the type of cardiomyopathy [124]. Figures 1 and 2 show
two typical gated SPECT studies in this kind of patient.
These two studies emphasise the advantage of combining
assessment of abnormalities in the myocardial perfusion
pattern, which correspond to the extent of fibrotic and/or
scarred areas, with a reproducible estimate of left ventric-
ular shape and function. In the same clinical setting, other
groups have used gated SPECT for the sole assessment of
left ventricular function, without considering the perfusion
pattern. Chen et al. used gated SPECT to evaluate the
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mechanical dyssynchrony in these patients, with the aim of
improving the detection of potential candidates for cardiac
resynchronisation therapy [125]. They were able to create a
normal database for the onset of mechanical contraction
using phase analysis of 99mTc-sestamibi gated SPECT
[125]. Using a dynamic display of the onset of mechanical
contraction, this method could be potentially helpful for
selecting those patients in whom the degree of left
ventricular dyssynchrony is predictive of a favourable
response to resynchronisation therapy [125]. Tsurugaya et
al. could classify patients into responders and non-respond-
ers to biventricular pacing on the basis of the improvement
in left ventricular synchrony assessed by gated SPECT
studies performed before and shortly after the onset of
cardiac resynchronisation therapy [126]. To this end they
used a simplified approach based on an asynchrony index
calculated from the difference between the frame number
showing the maximum systolic movement in the septum
and that showing the maximum systolic movement in the
lateral wall [126]. According to their results, the asynchro-
ny index significantly improved after resynchronisation
therapy in the responders, but not in the non-responders
[126]. These two reports indicate that perfusion gated
SPECT can be used in these patients with the same
effectiveness as ERNA, and is therefore a reasonable
alternative to gated blood pool SPECT.
There are other examples of gated SPECT studies that
did not consider the myocardial perfusion data, but
exclusively addressed the functional parameters. Also in
these reports, perfusion gated SPECT took the role that in
the past was often occupied by ERNA, with the advantage
over this latter modality that it is a three-dimensional
technique and allows the measurement of left ventricular
volumes. Schafers et al. employed gated SPECT to study
the functional changes after partial left ventriculectomy in
patients with dilated cardiomyopathy; they observed an
early reduction in left ventricular volumes with improve-
ment in ejection fraction, without further significant
changes at late follow-up, but with a trend to reverse
remodelling in good agreement with the clinical improve-
Fig. 1 Gated SPECT studies of a patient with severe heart failure
[New York Heart Association (NYHA) class III] on the basis of
ischaemic cardiomyopathy, scheduled for cardiac resynchronisation
therapy because of left bundle branch block with a wide QRS complex
(140 ms). In the left upper quadrant are the end-diastolic (ED) and
end-systolic (ES) three-dimensional images of the left ventricle at
baseline, and the right upper quadrant shows the corresponding short-
axis and vertical and horizontal long-axis slices. The left ventricle is
severely dilated (end-diastolic volume 375 ml), with a depressed
ejection fraction (19%). A wide and severe perfusion defect of the
infero-lateral wall can be readily recognised. In the left lower quadrant
are the three-dimensional images obtained 3 months after implantation
of a biventricular pacemaker, and the lower right quadrant shows the
related slices, demonstrating an unchanged perfusion pattern. Al-
though the QRS width was reduced (130 ms) and a slight subjective
improvement was reported by the patient (NYHA class II–III), the left
ventricle is even larger than before treatment (end-diastolic volume
387 ml) and the ejection fraction is further decreased (15%)
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ment [127]. In patients with severe left ventricular
dysfunction due to prior infarction who were submitted to
endoventricular circular patch plasty performed in addition
to coronary artery bypass grafting, Fujii et al. could
demonstrate a very good correlation between the parame-
ters derived from gated SPECT and those obtained using
left ventriculography [128]. Moreover, using gated SPECT
for prolonged follow-up, they observed a significant
reduction in left ventricular volumes and an increase in
ejection fraction, indicating the presence of both short- and
long-term reverse remodelling [129]. Akincioglu et al.
demonstrated the feasibility and reliability of the assess-
ment of diastolic function of the left ventricle by means of
16-frame gated SPECT, with results comparable to those of
gated blood pool studies [73]. In particular, they observed
that the gated SPECT time to peak filling was a stable
parameter and was not influenced by systolic function,
heart rate or age.
Finally, Htay et al. compared the functional parameters
derived from gated SPECT in diabetic patients with those
obtained in patients with a low-to-intermediate probability
of coronary artery disease, who had been submitted to rest-
stress myocardial perfusion imaging in the emergency
department because of non-specific symptoms [130]. They
demonstrated that in patients with type 2 diabetes there are
no differences in ejection fraction and left ventricular
volumes as compared to gender-matched controls without
diabetes [130]. However, in diabetic men the rate of
subjects with an abnormally low ejection fraction was
fourfold that among non-diabetic controls; this difference
was not registered in women [130]. In this study, gated
SPECT was performed with the clinical aim of examining
myocardial perfusion, but the authors’ research interest was
focussed on the functional data alone, and the perfusion
pattern was considered just to exclude the presence of
myocardial infarction or stress-induced ischaemia.
Gated SPECT versus other imaging modalities
There is no doubt that magnetic resonance imaging is the
reference method for assessment of left ventricular func-
tion, with the additional most important advantage that it
does not require the use of ionising radiation [131, 132].
However, in many circumstances its availability and
feasibility are probably inferior to those of gated SPECT.
Fig. 2 Gated SPECT of another patient with ischaemic cardiomyop-
athy, severe heart failure (NYHA class III) and left bundle branch
block with wide QRS (140 ms). Same image arrangement as in Fig. 1.
The baseline end-diastolic volume is 173 ml, and the ejection fraction,
28%; the myocardial perfusion is normal. At follow-up, there was the
same QRS width reduction as in the other subject, but this patient was
in NYHA class I, and a clear decrease in end-diastolic volume
(156 ml) and an improvement in the ejection fraction (33%) can be
observed
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The time required to acquire a magnetic resonance study
remains quite long, and this may be unbearable for
claustrophobic patients; furthermore, the use of magnetic
resonance is contraindicated in patients with pacemakers
and implantable cardioverter defibrillators [133].
Echocardiography is widely available, has limited costs
and does not require ionising radiation. Therefore, it is
certainly the technique with the greatest accessibility and
user-friendliness, and the only one that can be employed
directly at the patient’s bedside or in other crucial settings,
such as the cath lab. However, it is affected by acoustic
window limitations, particularly if high-quality definition of
endocardial borders is needed, is operator dependent, and
has suboptimal accuracy and reproducibility for quantita-
tive measurements. This last limitation is especially evident
in patients with abnormal ventricles, also because geometric
assumptions are needed with the standard two-dimensional
technique [131, 133–136]. It can be overcome by the use of
three-dimensional echocardiography, but this technique still
suffers from the problems of acoustic window and imaging
artefacts [133, 137].
Recent studies indicate that multi-slice computed to-
mography can effectively assess the left ventricular function
[138, 139]. However, the use of this technique for this
particular aim is still under evaluation, and various
limitations must be considered, such as the use of contrast
media, the need for low heart rates during acquisition and
the relatively prolonged post-processing [133]. Moreover,
there are no advantages in terms of radiation exposure
compared with gated SPECT [140]. In a most recent article,
exactly gated SPECT was used as a reference method to
validate the functional parameters derived from multi-slice
computed tomography [141].
In the research setting, the available data on the reliability
and reproducibility of gated SPECT functional parameters
are sufficient to justify the use of gated SPECT for the
evaluation of left ventricular function and not just as a
method for studying the perfusion pattern. For investiga-
tional purposes, gated SPECToffers various advantages over
competing modalities, and can probably be regarded as the
true successor of ERNA instead of gated blood pool SPECT.
Therefore, its use could be considered as a reasonable
standard for the assessment of ventricular function even in
multicentre studies, as recently suggested [68].
In everyday routine, however, it is much more difficult
to imagine widespread use of gated myocardial perfusion
SPECT exclusively for the evaluation of left ventricular
function. For almost all clinical purposes, the wide
availability and the lack of ionising radiation hazards will
certainly encourage practitioners to overlook the limitations
of echocardiography in terms of quantitation and reproduc-
ibility. Like ERNA formerly, gated myocardial perfusion
SPECT could be considered as an alternative just in the few
patients with a suboptimal acoustic window. However, even
in these subjects and more generally in all patients in whom
accurate quantification of left ventricular function is
required, magnetic resonance imaging remains the ideal
approach to functional evaluation.
On the other hand, if perfusion data are of some interest,
and this is often the case, there is nowadays no other
technique that allows the simultaneous assessment of
perfusion abnormalities and functional parameters with the
same ease and reliability as gated myocardial perfusion
SPECT [142]. Although both contrast echocardiography
and stress magnetic resonance first-pass perfusion have
great potential for myocardial perfusion imaging, these two
techniques have so far been studied in relatively small
populations, are quite demanding and have thus far
achieved only limited implementation in clinical practice
[142, 143]. Conversely, stress perfusion nuclear imaging
has been used for approximately 30 years, and its value in
heart disease has been extensively evaluated and demon-
strated in very large patient groups [144]. Furthermore,
nuclear perfusion imaging is the only technique that allows
reliable evaluation of myocardial perfusion during dynamic
exercise. Although the value of pharmacological stress
testing is undeniable, the importance of exercise-related
parameters for risk stratification cannot be exaggerated
[144, 145]. Multi-slice computed tomography is also
emerging as an alternative non-invasive approach for
coronary artery disease diagnosis [146]. However, this
method focusses on the anatomical abnormalities of the
epicardial coronary vessels instead of on the myocardial
perfusion pattern [147]. Therefore, its value for risk
stratification is still to be demonstrated [148].
Conclusion
Despite its reliability, gated SPECT will seldom be
preferred to other techniques only for the estimation of left
ventricular function. However, the functional parameters
achievable using gated myocardial perfusion SPECT are so
valuable that the possibility of obtaining them does not
merely encourage the use of perfusion gated SPECT for the
assessment of suspected or known coronary artery disease;
rather, it could even reasonably lead to the expansion of its
indications to various other clinical settings in which
perfusion imaging has not previously been considered.
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